Launch of the Australian Diabetes Clinical Trials Network
The Australian Centre for Accelerating Diabetes Innovations (ACADI) and Diabetes Australia have joined forces to announce the Australian Diabetes Clinical Trials Network (ADCTN), a research initiative designed to increase the number of diabetes clinical trials in Australia.
Pictured (L-R): Keren Pointon, Dr Lisa Hayes, Dr Anish Menon, Professor Elif Ekinci, Justine Cain, Susan Kozij, Professor David O’Neal, Professor Josephine Forbes, Professor Grant Brinkworth, and Andrew Bowskill.
This groundbreaking new collaboration in diabetes research was launched on 3 September 2024 in Brisbane, and will enhance research, improve care, and accelerate innovative treatments for people living with diabetes.
Diabetes Australia Group CEO Justine Cain said clinical trials are a cornerstone of medical research and innovation because of their real-world application.
“People living with diabetes are at the heart of everything we do,” Ms. Cain added. “Clinical trials ensure that new treatments deliver real benefits to people, while also identifying any potential risks or side effects.”
“Our new network will increase the number of diabetes clinical trials being funded and conducted in Australia. This will make a huge difference in the lives of people living with diabetes because it means new and innovative treatments and interventions can be tested and hopefully become available.”
ACADI Director and Head of the Department of Medicine in the Melbourne Medical School, Professor Elif Ekinci, said the network will support diabetes researchers by providing expert review and feedback of clinical trial protocols and grant funding applications.
“Clinical trials are essential to inform new ways to prevent, detect, or treat diabetes,” Professor Ekinci explained.
“By advancing our understanding of how different treatments work and evaluating their impact, clinical trials play a crucial role in improving the care of people living with diabetes. Their results contribute to the development of more effective, safer healthcare options and help inform evidence-based practices in medicine.”
Stay up to date by signing up to the ADCTN News.